abstract |
Compounds of this invention have the formula: X-(CH2)n-C(O)NH-A-C(COOR5)R3R4 or a pharmaceutically acceptable salt thereof, e.g. formula (1-7) which are useful for inhibiting fibrinogen binding to blood platelets, thereby inhibiting platelet aggregation. |